Option chain shows key data for Actavia Life Sciences's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Actavia Life Sciences.

Actavia Life Sciences (OTC:RASP) Stock, Option Chain

ACTAVIA LIFE SCIENCES INC by Actavia Life Sciences, Inc.

Actavia Life Sciences

Overview

Actavia Life Sciences Inc is a clinical-stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, mainly focusing on the treatment of leukemia. Its primary indication is Acute Myeloid Leukemia (AML), which may be fatal within weeks to months, has about a 5-year survival rate of only about 25% and very poor prospects for the long-term survival of patients.

Comments

Actavia Life Sciences Option Chain

No option chain data available. Please try again later